
Vaxx Research provides an AI-powered platform to speed up drug discovery for RNA vaccines, gene therapies, and cell treatments. CureiTec integrates AI, machine learning, big data analysis, and blockchain to accelerate target identification and ensure data integrity, with wet-lab validation support. It is offered as SaaS and licensing to biotech and pharmaceutical companies. The platform targets complex diseases such as cancer and autoimmune conditions, aiming for faster, more cost-effective research. Key technologies include AI, machine learning, blockchain, bioinformatics, NLP, and large language models.

Vaxx Research provides an AI-powered platform to speed up drug discovery for RNA vaccines, gene therapies, and cell treatments. CureiTec integrates AI, machine learning, big data analysis, and blockchain to accelerate target identification and ensure data integrity, with wet-lab validation support. It is offered as SaaS and licensing to biotech and pharmaceutical companies. The platform targets complex diseases such as cancer and autoimmune conditions, aiming for faster, more cost-effective research. Key technologies include AI, machine learning, blockchain, bioinformatics, NLP, and large language models.